SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024444
Filing Date
2022-11-10
Accepted
2022-11-10 16:06:18
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vor-20220930.htm   iXBRL 10-Q 2485907
2 EX-31.1 vor-ex31_1.htm EX-31.1 21341
3 EX-31.2 vor-ex31_2.htm EX-31.2 21345
4 EX-32.1 vor-ex32_1.htm EX-32.1 24433
  Complete submission text file 0000950170-22-024444.txt   7934473

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vor-20220930_def.xml EX-101.DEF 124467
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vor-20220930_pre.xml EX-101.PRE 234567
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vor-20220930_cal.xml EX-101.CAL 40798
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vor-20220930.xsd EX-101.SCH 39734
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vor-20220930_lab.xml EX-101.LAB 337839
55 EXTRACTED XBRL INSTANCE DOCUMENT vor-20220930_htm.xml XML 1591919
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 221377065
SIC: 2836 Biological Products, (No Diagnostic Substances)